Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 22136774)

Published in Gastrointest Endosc on December 01, 2011

Authors

Pietro Familiari1, Guido Costamagna, Daniel Bléro, Olivier Le Moine, Vincenzo Perri, Ivo Boskoski, Emmanuel Coppens, Marie Barea, Amerigo Iaconelli, Gertrude Mingrone, Christophe Moreno, Jacques Devière

Author Affiliations

1: Digestive Endoscopy Unit, Università Cattolica del Sacro Cuore, Gemelli University Hospital, Rome, Italy.

Associated clinical trials:

Endoscopic Bariatric Stapling Pilot Study (TOGA®) | NCT01067625

Endoscopic Gastric Plication for Weight Loss in Morbidly Obese Patients Prior to Incisional Hernia Repair | NCT02078934

Articles by these authors

Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med (2012) 11.25

Early liver transplantation for severe alcoholic hepatitis. N Engl J Med (2011) 8.50

A prospective trial comparing small bowel radiographs and video capsule endoscopy for suspected small bowel disease. Gastroenterology (2002) 7.97

Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. N Engl J Med (2009) 6.31

ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV. N Engl J Med (2014) 4.90

Endoscopic treatment for Zenker's diverticulum: long-term results (with video). Gastrointest Endosc (2013) 4.30

Nonresorbable copolymer implantation for gastroesophageal reflux disease: a randomized sham-controlled multicenter trial. Gastroenterology (2005) 3.39

Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data. Hepatology (2014) 3.30

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection. N Engl J Med (2015) 3.16

The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology (2009) 2.92

Feasibility and yield of a new EUS histology needle: results from a multicenter, pooled, cohort study. Gastrointest Endosc (2011) 2.82

Endoscopic drainage of pancreatic-fluid collections in 116 patients: a comparison of etiologies, drainage techniques, and outcomes. Gastrointest Endosc (2006) 2.79

Prophylaxis of post-ERCP pancreatitis: a practice survey. Gastrointest Endosc (2010) 2.57

Second-generation colon capsule endoscopy compared with colonoscopy. Gastrointest Endosc (2011) 2.55

Agile patency system eliminates risk of capsule retention in patients with known intestinal strictures who undergo capsule endoscopy. Gastrointest Endosc (2008) 2.42

Endoscopic removal of malfunctioning biliary self-expandable metallic stents. Gastrointest Endosc (2005) 2.41

Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). Gastrointest Endosc (2011) 2.30

Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol (2009) 2.28

Pancreatic-fluid collections: a randomized controlled trial regarding stent removal after endoscopic transmural drainage. Gastrointest Endosc (2007) 2.17

Advantages of multidisciplinary management of bile duct injuries occurring during cholecystectomy. Am J Surg (2008) 2.11

Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study. Am J Gastroenterol (2013) 2.11

Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg (2008) 2.06

A case series of symptomatic intraluminal duodenal duplication cysts: presentation, endoscopic therapy, and long-term outcome (with video). Gastrointest Endosc (2008) 2.06

Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes (2002) 2.06

Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis. Gastroenterology (2004) 2.02

EUS-guided pancreatogastrostomy and pancreatobulbostomy for the treatment of pain in patients with pancreatic ductal dilatation inaccessible for transpapillary endoscopic therapy. Gastrointest Endosc (2007) 2.01

The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C. Hepatology (2012) 1.97

Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA (2013) 1.94

Predicted effects of treatment for HCV infection vary among European countries. Gastroenterology (2012) 1.89

Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes (2006) 1.89

CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice. Hepatology (2005) 1.88

Ultraflex precision colonic stent placement as a bridge to surgery in patients with malignant colon obstruction. Gastrointest Endosc (2007) 1.87

Endoscopic removal of dysfunctioning bands or rings after restrictive bariatric procedures. Gastrointest Endosc (2009) 1.84

Endoscopic implantation of enteryx for treatment of GERD: 12-month results of a prospective, multicenter trial. Am J Gastroenterol (2003) 1.84

Endotherapy of postoperative biliary strictures with multiple stents: results after more than 10 years of follow-up. Gastrointest Endosc (2010) 1.77

Efficacy of endoscopic closure of acute perforations of the gastrointestinal tract. Clin Gastroenterol Hepatol (2012) 1.77

Endoscopic treatment of external pancreatic fistulas: when draining the main pancreatic duct is not enough. Am J Gastroenterol (2007) 1.74

Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis. J Hepatol (2011) 1.73

Self-expanding plastic stents for benign esophageal lesions. Gastrointest Endosc (2004) 1.72

EUS-guided Nd:YAG laser ablation of normal pancreatic tissue: a pilot study in a pig model. Gastrointest Endosc (2010) 1.72

Unexplained iron deficiency anaemia: Is it worthwhile to perform capsule endoscopy? Dig Liver Dis (2010) 1.68

Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology (2006) 1.68

Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma. Gastroenterology (2012) 1.67

Clinical impact of biliary drainage and jaundice resolution in patients with obstructive metastases at the hilum. Am J Gastroenterol (2003) 1.67

Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma. Clin Cancer Res (2009) 1.62

Enteryx implantation for GERD: expanded multicenter trial results and interim postapproval follow-up to 24 months. Gastrointest Endosc (2005) 1.62

Ultraflex precision colonic stent placement for palliation of malignant colonic obstruction: a prospective multicenter study. Gastrointest Endosc (2007) 1.59

Efficacy of main pancreatic-duct endoscopic drainage in patients with chronic pancreatitis, continuous pain, and dilated duct. Gastrointest Endosc (2005) 1.59

Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease. J Hepatol (2010) 1.57

Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest Endosc (2004) 1.56

Video capsule enteroscopy in the diagnosis of celiac disease: a multicenter study. Am J Gastroenterol (2007) 1.53

EUS-guided pancreaticogastrostomy. Gastrointest Endosc (2002) 1.50

Endoscopic cystenterostomy of nonbulging pancreatic fluid collections. Gastrointest Endosc (2002) 1.50

The prognostic effect of clinical staging in pancreatic adenocarcinoma. Ann Surg Oncol (2005) 1.50

Literature review and recommendations for clinical application of Colon Capsule Endoscopy. Dig Liver Dis (2010) 1.50

Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Hepatology (2011) 1.49

Reduced medication dependency and improved symptoms and quality of life 12 months after enteryx implantation for gastroesophageal reflux. J Clin Gastroenterol (2005) 1.46

Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transpl Int (2003) 1.44

A new low-volume isosmotic polyethylene glycol solution plus bisacodyl versus split-dose 4 L polyethylene glycol for bowel cleansing prior to colonoscopy: a randomised controlled trial. Dig Liver Dis (2012) 1.42

Self-expandable metal stents for the treatment of benign upper GI leaks and perforations. Gastrointest Endosc (2011) 1.42

The European experience with double-balloon enteroscopy: indications, methodology, safety, and clinical impact. Gastrointest Endosc (2005) 1.41

Microsatellite polymorphism in the heme oxygenase-1 gene promoter is not associated with alcoholic liver disease severity. Hepatology (2013) 1.39

Peroral endoscopic myotomy (POEM) for oesophageal achalasia: preliminary results in humans. Dig Liver Dis (2012) 1.35

EUS-guided fine-needle tissue acquisition by using a 19-gauge needle in a selected patient population: a prospective study. Gastrointest Endosc (2011) 1.33

Successful endoscopic closure of a lateral duodenal perforation at ERCP with fibrin glue. Gastrointest Endosc (2006) 1.29

Influence of maternal obesity on insulin sensitivity and secretion in offspring. Diabetes Care (2008) 1.28

Management of hilar biliary strictures. Am J Gastroenterol (2007) 1.27

Hemostasis of Dieulafoy's lesions by argon plasma coagulation (with video). Gastrointest Endosc (2007) 1.27

PillCam colon capsule endoscopy: a prospective, randomized trial comparing two regimens of preparation. J Clin Gastroenterol (2011) 1.26

Endoscopic implantation of a biopolymer in the lower esophageal sphincter for gastroesophageal reflux: a pilot study. Gastrointest Endosc (2002) 1.25

Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. J Hepatol (2011) 1.23